Emergent BioSolutions (EBS) PT Raised to $112 at Wells Fargo
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.59 +2.23%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wells Fargo analyst David Maris raised the price target on Emergent BioSolutions (NYSE: EBS) to $112.00 (from $110.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Emergent BioSolutions (EBS) PT Lowered to $10 at H.C. Wainwright
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR375 at ICICI Securities
- KP Tissue Inc. (KPT:CN) (KPTSF) PT Raised to Cdn$13.50 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
